Skip to main content
Skip to footer


  • Although the healthcare industry generates around 30% of the world's data, the segregated data is of limited use. 
  • Regulatory agencies are working toward enhancing interoperability and standardizing datasets for organizations to collaborate and analyze this data.
  • Real-world evidence (RWE)—the information derived from real-world data (RWD)—is of immense value. In 2020, this formed the basis of approvals for drug development for 75% of contagious diseases cases and 90% of oncology cases.
  • TCS applies its extensive domain expertise and brings together the healthcare ecosystem to boost RWE adoption. 
  • Our solutions facilitate real-world evidence study design and management and enable life sciences companies with health economics and outcomes research (HEOR) and market access service portfolios.